QT
CGON icon

Quantbot Technologies’s CG Oncology CGON Stock Holding History

Quantbot Technologies’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.03K Sell
113
-2,770
-96% -$181K ﹤0.01% 1849
2026
Q1 		$195K Buy
+2,883
New +$163K 0.01% 1180
2025
Q1 		– Sell
-7
Closed -$201 – 1515
2024
Q4 		$201 Buy
+7
New +$239 ﹤0.01% 1418

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantbot Technologies's CGON Position: Q2 2026 in Review

Quantbot Technologies reduced its CG Oncology (CGON) stake by 96% in Q2 2026, selling an estimated $181K and leaving 113 shares worth $8.03K. The position accounts for ﹤0.01% of the portfolio, ranked #1849.

Quantbot Technologies first reported a position in CGON in Q4 2024 and has held it in 3 quarters since. The position peaked at $195K in Q1 2026. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Quantbot Technologies held 113 shares of CG Oncology worth $8.03K as of Q2 2026.
  • Quantbot Technologies sold 2,770 CG Oncology shares in Q2 2026, an estimated $181K.
  • CG Oncology made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1849 holding.
  • Quantbot Technologies first reported a position in CG Oncology in Q4 2024 and has held it in 3 quarters since.
  • Quantbot Technologies's CG Oncology position peaked at $195K in Q1 2026.
  • 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.